Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer: [formula omitted], C.F.M. Sier, M.M. Heerding, J.H.J.M. van Krieken 1, G. Griffioen, C.J.H. van de Velde 2, C.B.H.W. Lamers, H.W. Verspaget. Depts. Gastroenterology, Pathology 1, and Surgery 2, University Hospital Leiden, The Netherlands

doi:10.1016/0016-5085(95)26202-4

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer: [formula omitted], C.F.M. Sier, M.M. Heerding, J.H.J.M. van Krieken 1, G. Griffioen, C.J.H. van de Velde 2, C.B.H.W. Lamers, H.W. Verspaget. Depts. Gastroenterology, Pathology 1, and Surgery 2, University Hospital Leiden, The Netherlands

Open Access

https://doi.org/10.1016/0016-5085(95)26202-4

Copy DOI

Journal: Gastroenterology

Publication Date: Apr 1, 1995

#Contribution Of Plasminogen Activators #University Hospital Leiden + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer: [formula omitted], C.F.M. Sier, M.M. Heerding, J.H.J.M. van Krieken 1, G. Griffioen, C.J.H. van de Velde 2, C.B.H.W. Lamers, H.W. Verspaget. Depts. Gastroenterology, Pathology 1, and Surgery 2, University Hospital Leiden, The Netherlands

Full Text